Crohn’s is an autoimmune disorder that causes inflammation and damage to the gastrointestinal (GI) tract, according to the U.S. Centers for Disease Control and Prevention.

John R. Saltzman, MD, discusses the most topical issues in endoscopy at DDW 2003, the focus of which is video capsule endoscopy -- a novel technology designed primarily to image the small intestine.

Rinvoq is the first oral drug for moderate to severe Crohn’s disease — a chronic intestinal disorder — to be approved by the Food and Drug Administration.

Crohn’s disease develops when your immune system attacks healthy cells in your GI tract. IBS is associated with many factors, like food intolerances and a disruption in your gut microbiome.

When I’m talking to patients, those are actually the words that I’ll use is that ulcerative colitis is confined to the colon and Crohn’s disease can be anywhere in the GI tract from your ...

Get Instant Summarized Text (Gist) Abnormal immune cell function in the gastrointestinal tract may lead to Crohn's disease. Gamma delta intraepithelial lymphocytes (IELs), crucial for maintaining ...

About AGMB-129 AGMB-129 is an oral, small molecule GI-restricted inhibitor of ALK-5 (or TGF β R1) for the treatment of Fibrostenosing Crohn’s Disease (FSCD).